Meeting
2020 Genitourinary Cancers Symposium
Outcomes of adult urogenital sarcomas: Analysis of surveillance, epidemiology, and end results (SEER) database 2004 to 2015.
Authors
Snigdha Nutalapati
University of Kentucky, Lexington, KY
Snigdha Nutalapati , Quan Chen , Bin Huang , Reema Anil Patel , Mehmet Asim Bilen , Zin Myint
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer
Sub Track
Other
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 423)
Abstract #
423
Poster Bd #
E22
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Facility type as a prognostic factor? The role of academic centers in outcomes and treatment for patients with leiomyosarcoma.
First Author: Jaikin Patel
Poster
2016 ASCO Annual Meeting
Phase II clinical trial evaluating the activity and tolerability of pazopanib in patients (pts) with advanced and/or metastatic liposarcoma (LPS): A joint Spanish Sarcoma Group (GEIS) and German Interdisciplinary Sarcoma Group (GISG) Study—NCT01692496.
First Author: Claudia María Valverde
Poster
2016 ASCO Annual Meeting
Trabectedin for advanced soft-tissue sarcoma: A single-center experience of over 10 years.
First Author: Imran Syed
Poster
2015 ASCO Annual Meeting
Pazopanib for soft tissue sarcoma (STS) in the first- line setting with denosumab.
First Author: Hiroyuki Narahara